Skip to main content
letter
. 2018 Jan-Feb;93(1):154–155. doi: 10.1590/abd1806-4841.20186613

Figure 2.

Figure 2

A: Intense proliferation of pleomorphic cells in the dermis (Hematoxylin & eosin, X200); B: Infiltration of adipose tissue with neovascularization (Hematoxylin & eosin, X100); C: Fusiform and polygonal pleomorphic multinucleated cells with hyperchromasia of the nucleoli and mitotic figures (Hematoxylin & eosin, X400); D: Immunohistochemistry 90% highly positive for Ki-67 antibody, a cell proliferation marker, CD-68; E: A macrophage marker (IHC, X200); and F: Vimentin, a mesenchymal cell marker, IHC X100).